Are you Dr. Potter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2101 Fm 369 N
Iowa Park, TX 76367Phone+1 940-855-7477
Summary
- Dr. David Potter, DO is a family physician in Iowa Park, Texas. He is currently licensed to practice medicine in Texas.
Education & Training
Creighton University School of Medicine (Omaha)Residency, Family Medicine, 1988 - 1990
Texas College of Osteopathic MedicineClass of 1984
Certifications & Licensure
TX State License 1985 - 2015
Publications & Presentations
PubMed
- 1 citationsCorrigendum: Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival.Dennis S. Rice, Jorgelina M. Calandria, William C. Gordon, Bokkyoo Jun, Yongdong Zhou
Nature Communications. 2015-05-12 - 62 citationsFrizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier.Kim Paes, Ernest Wang, Kathy Henze, Peter Vogel, R. Read
Investigative Ophthalmology & Visual Science. 2011-08-16 - 50 citationsOpioid receptor-activation: retina protected from ischemic injury.Shahid Husain, David E. Potter, Craig E. Crosson
Investigative Ophthalmology & Visual Science. 2009-08-01
Grant Support
- Ocular Hydrodynamics: Modulation By OpioidsNational Eye Institute2002–2004
- Ocular Natriuretic Peptide Activity: Modulation By DrugsNational Eye Institute2002
- Ocular Hydrodynamics: Modulation By OpioidsNational Eye Institute2002
- Ocular Natriuretic Peptide Activity: Modulation By DrugsNational Eye Institute2000–2001
- Ocular Hydrodynamics--Modulation By OpioidsNational Eye Institute1998–2001
- Alpha 2, I1 &Da2 Agonists--Potential Antiglaucoma DrugsNational Eye Institute1994–1997
- Dopamine And A2 Agonists: Potential Antiglaucoma DrugsNational Eye Institute1991–1993
- Dopamine Agonist--Potential Antiglaucoma DrugsNational Eye Institute1989
- Dopamine Agonists: Potential Antiglaucoma DrugsNational Eye Institute1987–1988
- Dopamine Agonist: Potential Antiglaucoma DrugsNational Eye Institute1985–1986
- Dopamine Agonists Potential Antiglaucoma DrugsNational Eye Institute1985
